Brand Insights

The Rise of the Letter Y in Pharmaceutical Brand Naming

The use of the letter y in pharmaceutical brand names has been steadily increasing over the last two decades. In the five-year […]

A Suffix Like No Other – Navigating the Nonproprietary Naming of Biological Products

The “Nonproprietary Naming of Biological Products” draft guidance was published by the Food and Drug Administration (FDA) in August 2015 […]

Naming Strategies in Pharmaceutical Brand Name Development

One of the questions I am often asked about pharmaceutical brand naming is, “Where do you start?” The public, and […]

Standing Out in the Nonproprietary Naming Arena

When it comes to developing nonproprietary names for pharmaceuticals and biologics, the goal remains consistent: to obtain an appropriate name […]